In a filing, Immunome Inc revealed its President and CEO SIEGALL CLAY B acquired Company’s shares for reported $0.28 million on May 21 ’24. In the deal valued at $13.78 per share,20,434 shares were bought. As a result of this transaction, SIEGALL CLAY B now holds 419,636 shares worth roughly $6.26 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, BIENAIME JEAN JACQUES bought 2,000 shares, generating $27,140 in total proceeds. Upon buying the shares at $13.57, the Director now owns 9,615 shares.
Before that, SIEGALL CLAY B bought 79,566 shares. Immunome Inc shares valued at $1,106,524 were divested by the President and CEO at a price of $13.91 per share. As a result of the transaction, SIEGALL CLAY B now holds 399,202 shares, worth roughly $5.96 million.
Piper Sandler initiated its Immunome Inc [IMNM] rating to an Overweight in a research note published on May 31, 2024; the price target was $27. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. Guggenheim began covering IMNM with “Buy” recommendation on April 15, 2024. Leerink Partners started covering the stock on January 29, 2024. It rated IMNM as “an Outperform”.
Price Performance Review of IMNM
On Friday, Immunome Inc [NASDAQ:IMNM] saw its stock fall -6.98% to $14.92. Over the last five days, the stock has lost -1.84%. Immunome Inc shares have risen nearly 39.44% since the year began. Nevertheless, the stocks have risen 182.58% over the past one year. While a 52-week high of $30.96 was reached on 03/07/24, a 52-week low of $5.20 was recorded on 01/02/24. SMA at 50 days reached $15.78, while 200 days put it at $13.97. A total of 0.9 million shares were traded, compared to the trading of 0.44 million shares in the previous session.
Levels Of Support And Resistance For IMNM Stock
The 24-hour chart illustrates a support level at 14.32, which if violated will result in even more drops to 13.71. On the upside, there is a resistance level at 15.92. A further resistance level may holdings at 16.92. The Relative Strength Index (RSI) on the 14-day chart is 46.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.49, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 64.22%. Stochastics %K at 61.37% indicates the stock is a holding.
The most recent change occurred on December 19, 2023 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $12 price target.
